IP Library › Granted Patent US 6,867,299
Granted Patent B2
US 6,867,299 · App. 09/779,116 · Granted Mar 15, 2005

Oxamide IMPDH inhibitors

Assignee: Hoffmann-La Roche Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,867,299
App. No.
09/779,116
Granted
Mar 15, 2005
Kind
B2
Abstract

Disclosed are compounds of the general formula which are oxamide derivatives and inhibitors of the enzyme inosine monophosphate dehydrogenase (IMPDH).

Claims (162)

1. The compound of the formula

wherein

R 2 is hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, hydroxy or cyano;

R 3 is hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano;

R 5 is hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano;

R 6 is hydrogen, unsubstituted lower alkyl, lower alkoxy, halo, or cyano;

R 7 is hydrogen, or unsubstituted lower alkyl;

R 9 is hydrogen, lower alkyl, or aryl-lower alkyl; and

R 10 is hydrogen

R 11 is H or lower alkyl, R 13 is H or unsubstituted lower alkyl,

n=0 or 1,

R a , R b are lower alkyl or R a and R b taken together with the carbon atom to which they are attached form a 3 to 7 member carbocycle, and

R 12 is heterocyclyl, aryl or lower cycloalkyl and Z is O, S or NR 28 ,

wherein R 28 is H or lower alkyl.

2. The compound of claim 1 of the formula

wherein

R 11 is H or lower alkyl, R 13 is H or unsubstituted lower alkyl,

n=0 or 1 and

R 12 is heterocyclyl, aryl or lower cycloalkyl.

3. The compound of claim 2 wherein

R 2 is methoxy and R 3 , R 5 , R 6 , R 9 , R 10 , R 11 and R 13 are hydrogen.

4. The compound of claim 3 wherein R 12 is aryl, a 3 to 7 membered cycloalkyl ring, or a 5 or 6-membered monocyclic or 9 or 10-membered bicyclic saturated or unsaturated heterocyclic ring with 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulfur.

5. The compound of claim 4 selected from the group consisting of:

Name

Structure

N-[3-(4-Hydroxy-phenoxy)-1,1- dimethyl-propyl]-N′-(3-methoxy-4- oxazol-5-yl-phenyl)-oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(4- methoxyphenoxy)-1,1- dimethylpropyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(4- nitrophenoxy)propyl]oxalamide

N-[3-(2-Hydroxyphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(4-Amino-phenoxy)-1,1- dimethyl-propyl]-N′-(3-methoxy-4- oxazol-5-yl-phenyl)-oxalamide

N-[3-(-Acetylamino-phenoxy)- 1,1-dimethyl-propyl]-N′-(3- methoxy-4-oxazol-5-yl-phenyl)- oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(3- pyridyloxy)propyl]oxalamide

N-[3-(3-Hydroxyphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(3- methoxyphenoxy)-1,1- dimethylpropyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(3- nitrophenoxy)propyl]oxalamide

N-[3-(3-Aminophenoxy)-1,1- dimethylpropyl)-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilio]oxalyl]amino]-3- methylbutoxy]benzoic acid

2-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

3-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

2-[4-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]anino]-3- methylbutoxy]phenoxy]acetic acid

2-[2-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]phenoxy]acetic acid

N-[3-Methoxy-4-(5- oxazolyl)phenyl]-N′-(1,1-dimethyl- 3-phenoxypropyl)oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(1- oxido-3-pyridyloxy)propyl] oxalamide

N-[3-(3,4-Dihydroxyphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-[4- (methylcarbamoyl)phenoxy]propyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(3,4- dimethoxyphenoxy)-1,1- dimethylpropyl]oxalamide

N-[3-[4-[(2-Hydroxyethyl) carbamoyl]phenoxy]-1,1-dimethyl- propyl]-N′-[3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[3-(3-Chlorophenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(3- pyridyloxy)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2- pyridyloxy)propyl]oxalamide

2-[4-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]phenyl]acetic acid

2-[3-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]phenyl]acetic acid

4-[2-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-2- methylpropoxy]benzoic acid

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]-2-methylbenzoic acid

3-[3-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]phenyl]propionic acid

3-[4-[3-[[[3-Methoxy-4- (5oxazolyl)anilino]oxalyl]amino]- 3-methylbutoxy]phenyl]propionic acid

3-[2-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]phenyl]propionic acid

2-[3-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- 3-methylbutoxy]phenoxy]acetic acid

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl-amino]-3- methylbutoxy]-3-methylbenzoic acid

N-[3-(4-Cyano-2- methoxyphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(3-Cyanophenoxy-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-[4-(4-Acetyl-1-piperazinyl) phenoxy]-1,1-dimethylpropyl]-N′- [3-methoxy-4-(5-oxazolyl)phenyl] oxalamide

N-[3-Methoxy-4-(5- oxazolyl)phenyl]-N′-[1,1-dimethyl- 3-(2-morpholinophenoxy)propyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-[3- (dimethylamino)phenoxy] propyl]oxalamide

N-[3-(1,3-Benzodioxol-5-yloxy)- 1,1-dimethylpropyl]-N′-[3- methoxy-4-(5-oxazolyl)phenyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(3,4,5- trimethoxyphenoxy)-1,1- dimethylpropyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(3,5- dimethoxyphenoxy)-1,1- dimethylpropyl]oxalamide

N-[3-(5,6,7,8-Tetrahydro-5-oxo-2- naphthyloxy)-1,1-dimethylpropyl]- N′-(3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[3-(2-Acetamido-5- methylphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(3-Acetamidophenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(1H-Indol-4-yloxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(2-Fluoro-6- methoxyphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-2-oxo- 2H-1-benzopyran-7- yloxy)propyl]oxalamide

N-[3-(4-Acetyl-3-methylphenoxy)- 1,1-dimethylpropyl]-N′-[3- methoxy-4-(5-oxazolyl)phenyl] oxalamide

(E)-N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-[4-(3- oxo-1-butenyl)phenoxy]propyl] oxalamide

N-[3-(3-Acetylphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(4-Acetylphenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(4-Acetamido-2- chlorophenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5- oxazolyl)phenyl]-N′-[1,1-dimethyl- 3-(4-pyridyloxy)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(1- oxido-4-pyridyloxy)propyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2,6- dimethyl-4-pyridyloxy)propyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2,6- dimethyl-1-oxido-4-pyridyloxy) propyl]oxalamide

N-[2-(4-Cyanophenoxy)-1,1- dimethylethyl)-N′-(3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[3-(2-methoxy-4- pyridyloxy)-1,1-dimethylpropyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-2-[4-(1H- tetrazol-5-yl)phenoxy]ethyl] oxalamide

N-[3-(4-Cyanophenoxy)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[2-(3-Cyanophenoxy)-1,1- dimethylethyl)-N′-[3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-2-[3-(1H- tetrazol-5-yl)phenoxy]ethyl] oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-[4-(1H- tetrazol-5-yl)phenoxy]propyl] oxalamide

Benzyl 2-methoxy-4-[3-[[[3- methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]benzoate

3-Chloro-4-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

2-Methoxy-4-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

3-Methoxy-4-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

2-Chloro-4-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl)amino]-3- methylbutoxy-benzoic acid

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]-2- quinolinecarboxylic acid

(cis/trans)-4-[3-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]-1- cyclohexanecarboxylic acid

(cis/trans)-4-[2-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-2- methylpropoxy]-1- cyclohexanecarboxylic acid

3-Fluoro-4-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy)benzoic acid

3-Acetamido-4-[3-[[[3-methoxy-4- (5-oxazolyl)anilino)oxalyl]amino]- 3-methylbutoxy]benzoic acid

3-(Methanesulfonamido)-4-[3-[[[3- methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutoxy]benzoic acid

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]-3,5-dimethylbenzoic acid

3-[3-[[[3 -Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutoxy]-2- pyridinecarboxylic acid

8-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino)-3- methylbutoxy]-2- quinolinecarboxylic acid

5-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino)oxalyl]amino]-3- methylbutoxy]-2-indolecarboxylic acid

6. The compound of claim 1 of the formula:

wherein

R 11 is H or lower alkyl, R 13 is H or unsubstituted lower alkyl,

n=0 or 1, m=1 to 5 and,

R 12 is heterocyclyl, aryl or lower cycloalkyl.

7. The compound of 6 wherein

R 2 is methoxy and R 3 , R 5 , R 6 , R 9 , R 10 , R 11 and R 13 are hydrogen.

8. The compound of claim 7 wherein R 12 is aryl, a 3 to 7 membered cycloalkyl ring, or a 5 or 6-membered monocyclic or 9 or 10-membered bicyclic saturated or unsaturated ring with 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulfur.

9. The compound of claim 8 selected from the group consisting of:

4-[2-[1-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclopropyl]ethoxy]benzoic acid

Benzyl 4-[2-[1-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclobutyl]ethoxy]benzoate

Benzyl 4-[2-[1-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclopentyl]ethoxy]benzoate

Benzyl 4-[2-[1-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclohexyl]ethoxy]benzoate

4-[2-[1-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclopentyl]ethoxy]benzoic acid

4-[2-[1-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclohexyl]ethoxy]benzoic acid

and

4-[2-[1-[[[3-Methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-1- cyclobutyl]ethoxy]benzoic acid

10. The compound of claim 1 of the formula

11. The compound of claim 10 wherein

R 2 is methoxy and R 3 , R 5 , R 6 , R 9 , R 10 , R 11 and R 13 are hydrogen.

12. The compound of claim 11 wherein R 12 is aryl, a 3 to 7 membered cycloalkyl ring, or a 5 or 6-membered monocyclic or 9 or 10-membered bicyclic saturated or unsaturated heterocyclic ring with 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulfur.

13. The compound of claim 12 selected from the group consisting of:

Name

Structure

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-2- (phenylthio)ethyl]oxalamide

N-[2-(4-Hydroxyphenylthio)-1,1- dimethylethyl]-N′-[3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-2- (phenylthio)ethyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-2-(2- pyridylthio)ethyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2- pyridylthio)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2- thienylthio)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2- pyrimidylthio)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(4- pyridylthio)propyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(2- thiazolylthio)propyl]oxalamide

N-[3-(4-Hydroxyphenylthio)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-Methoxy-4-(5-oxazolyl) phenyl]-N′-[1,1-dimethyl-3-(5- methyl-1,3,4-thiadiazol-2-ylthio) propyl]oxalamide

N-[3-(2-Benzooxazolylthio)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

N-[3-(2-Benzothiazolylthio)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

Methyl 4-[2-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-2- methylpropylthio]benzoate

tert-Butyl 6-[3-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-3- methylbutylthio]-3- pyridinecarboxylate

6-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylthio]-3- pyridinecarboxylic acid trifluoroacetate (1:1)

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylthio]benzoic acid

N-[2-(4-Benzyloxyphenylthio)-1,1- dimethylethyl]-N′-[3-methoxy-4-(5- oxazolyl)phenyl]oxalamide

N-[2-(4-Benzyloxyphenylthio)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

2-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylthio]-5- benzoxazolecarboxylic acid

N-[3-(1H-Imidazol-2-ylthio)-1,1- dimethylpropyl]-N′-[3-methoxy-4- (5-oxazolyl)phenyl]oxalamide

2-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylthio]-3- pyridinecarboxylic acid trifluoroacetate (1:1)

4-[2-[[[3-methoxy-4-(5- oxazolyl)anilino]oxalyl]amino]-2- methylpropylthio]benzoic acid

and

2-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylthio]-6- benzoxazolecarboxylic acid

14. The compound of claim 1 of the formula

15. Compound of claim 14 , wherein R 2 is methoxy and R 3 , R 5 , R 6 , R 9 , R 10 , R 11 and R 13 are hydrogen and R 28 is hydrogen or methyl.

16. The compound of claim 15 wherein R 12 is aryl.

17. The compound of claim 16 selected from the group consisting of:

Name

Structure

N-[3-Methoxy-4-(5-oxazolyl) phenyl)-N′-[1,1-dimethyl-2-(N methylanilino) ethyl] oxalamide

N-(3-Anilino-1,1-dimethylpropyl)- N′-[3-methoxy-4-(5-oxazolyl) phenyl]oxalamide hydrochloride (1:1)

4-[3-[[[3-Methoxy-4-(5-oxazolyl) anilino]oxalyl]amino]-3- methylbutylamino]benzoic acid

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2001
From: ROCHE PRODUCTS LIMITED
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 011882/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2001
From: F. HOFFMAN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 011882/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2001
From: BROADHURST, MICHAEL JOHN; HILL, CHRISTOPHER HUW; HURST, DAVID NIGEL; JONES, PHILIP STEPHEN; KAY, PAUL BRITTAIN; KILFORD, IAN REGINALD; MCKINNELL, ROBERT MURRAY
To: ROCHE PRODUCTS LIMITED
Reel/Frame 011894/0505 →
Priority Claims (3)
GB 0004392 · Feb 24, 2000 · national
GB 0015877 · Jun 28, 2000 · national
GB 0020322 · Aug 17, 2000 · national
Continuity (1)
Related Publication 20020052513A1 · May 2, 2002